Quite clearly shows all the assets were sold. Literally states it comprised all of the companies assets except for the cash, AR, some office furniture, inventory and the contracts that nobody wanted. So yes it’s ALL of the assets of value
On October 22, 2018, the Company completed the sale of certain of its assets to LCY Biotechnology Inc. (previously 9384-3076 Québec Inc.). These assets comprised all of the Company’s assets, save and except for the cash, accounts receivable and inventory of the Company, and also excluded certain U.S. based office equipment. The purchaser did not seek the assignment of the Company’s contracts, which meant that certain intellectual property under license from third parties was also not transferred to the purchaser.”
BioAmber has nothing left at all and shareholders got nothing for their wasted money